INTRODUCTION

Dulaglutide (brand name Trulicity) is glucagon-like peptide 1 (GLP-1) receptor agonist that consists of 2 identical disulfide-linked chains, each containing a modified human glucagon-like peptide 1 (GLP-1) linked to an Fc fragment of human IgG4. Dulaglutide is a medication that is used for the treatment of type 2 diabetes in combination with diet and exercise.

This plasmid is designed for expressing Dulaglutide in mammalian expression system.

PRODUCT INFORMATION

Item No.: PPBD-62
Shipping: Lyophilized plasmid, or liquid plasmid, or plasmids on filter paper
Storage: -20 °C or 4°C according to instruction
Plasmid Backbone: Expression plasmid, flexible options for promoter and selection marker, custom available
Quality Control: Sequencing validation

DRUG INFORMATION

Generic Name: Dulaglutide
Brand Name(s): Trulicity
Classification: Fusion proteins, Hormones
Amino Acid Sequence: Identical to DB09045

PROTOCOL FOR PLASMID RECOVERY FROM FILTER PAPER

REFERENCE

[1] Sanford M. Dulaglutide: first global approval. Drugs. 2014 Nov;74(17):2097-103.

[2] Burness CB, Scott LJ. Dulaglutide: A Review in Type 2 Diabetes. BioDrugs. 2015 Dec;29(6):407-18.

Contact Us